HLA-DR molecules enhance signal transduction through the CD3/Ti complex in activated T cells |
| |
Authors: | Niels Ø dum,Paul J. Martin,Gary L. Schieven,Susan Masewicz,John A. Hansen,Jeffrey A. Ledbetter |
| |
Affiliation: | The Clinical Research Division, Red Hutchinson Cancer Research Center, University of Washington, USA;Department of Medicine, University of Washington, USA;Oncogen/Bristol-Myers Squibb, Seattle, USA |
| |
Abstract: | Abstract: Crosslinking HLA-DR molecules by monoclonal antibodies (mAb) induces protein tyrosine phosphorylation and results in a secondary elevation of free cytoplasmic Ca2+ concentration ([Ca2+]i) in activated human T cells. Here we have studied the effect of DR on CD3-induced signal transduction in allospecific T-cell clones and T-leukemia (HUT78) cells. Co-crosslinking of DR with CD3 produced an enhanced [Ca2+]i response compared to that seen with CD3 alone. In contrast, CD2 responses were not enhanced by co-crosslinking with DR. Co-crosslinking CD45 in a tri-molecular complex of CD45, CD3, and DR completely abrogated the enhancing effects of DR on CD3-induced [Ca2+]i responses. In contrast, the enhancing effect of co-crosslinking CD4 on CD3 responses was not inhibited by co-crosslinking CD45. Thus, the DR-mediated accessory signals appear to be regulated differently from those provided by CD4 accessory molecules. The present data confirm, at the level of second messengers, recent findings suggesting that DR molecules have accessory functions in CD3/Ti-mediated T-cell responses. |
| |
Keywords: | T cell activation signal transduction HLA-DR HLA-class II |
|
|